Enoxaparin (Pediatric)

A Low Molecular Weight Heparin (LMWH). Dosing in infants is significantly higher than in adults to achieve the same anticoagulant effect.

Dosage by Body Weight

Treatment dose (Infants <2 months): 1.5 mg/kg every 12 hours. Children >2 months: 1 mg/kg every 12 hours. Monitor Anti-Xa levels.

Weight-based dosage tracking table for Enoxaparin (Pediatric), including body weight, dose, frequency, and tracking notes.
Body Weight	Dose	Frequency	Tracking Notes
5-10 kg	5 mg to 10 mg	Every 12 hours	Inject subcutaneously into the abdomen or thigh.

Injection (Prefilled Syringe)

Prevention and treatment of Deep Vein Thrombosis (DVT) and pulmonary embolism in children.

Enoxaparin (Pediatric) is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

CAUTION

Enoxaparin (Pediatric): Alcohol can increase bleeding risk or interfere with clotting control. Avoid or limit alcohol and seek medical advice.

CAUTION

Enoxaparin (Pediatric): Use during pregnancy only under specialist direction; some blood-thinning medicines are unsafe in pregnancy.

SAFE IF PRESCRIBED

Enoxaparin (Pediatric): Use while breastfeeding only with healthcare provider guidance and monitoring where needed.

SAFE

Enoxaparin (Pediatric): Usually does not impair alertness, but avoid driving if bleeding, weakness, dizziness, or illness occurs.

CAUTION

Enoxaparin (Pediatric): Liver disease can increase bleeding risk and affect clotting. Use only with medical monitoring.

CAUTION

Enoxaparin (Pediatric): Kidney impairment can affect dosing or bleeding risk for some anticoagulants. Monitoring may be required.